IVM, or in vitro maturation, is a fertility treatment where immature eggs are collected from the ovaries and matured in a laboratory before fertilization. Unlike conventional IVF, which requires weeks of hormone injections to grow eggs to full size inside the body, IVM retrieves eggs early from small follicles and finishes the maturation process in a specialized culture dish. This makes it a lighter, less expensive alternative for certain patients, particularly women with polycystic ovary syndrome (PCOS).
How IVM Differs From Standard IVF
In a typical IVF cycle, you receive daily hormone injections for roughly 10 to 14 days to stimulate your ovaries into producing multiple large, mature eggs. Those hormones push your body into overdrive, which is effective but comes with side effects, monitoring appointments, and cost.
IVM skips most of that stimulation. Eggs are retrieved from small follicles (about 2 to 10 mm in diameter) that haven’t been exposed to the hormones that trigger final maturation. In some newer protocols, patients receive just three days of a low dose of follicle-stimulating hormone before retrieval on day five. The eggs come out immature, and the lab takes over from there. That dramatically reduces the medication burden, the number of ultrasound and blood draw visits, and the overall cost per cycle.
What the Procedure Looks Like
An IVM cycle is noticeably shorter and simpler than a standard IVF cycle. Here’s how it typically unfolds:
- Cycle preparation: You may take birth control pills briefly to synchronize your menstrual cycle, followed by a baseline ultrasound and blood draw.
- Minimal stimulation (if any): Some clinics use a short course of hormone injections (around three days), while others use none at all. Either way, the goal is not to grow the follicles to full size.
- Egg retrieval: A transvaginal ultrasound-guided procedure collects immature eggs from small antral follicles, usually when the largest follicles reach about 10 to 12 mm.
- Lab maturation: The eggs are placed in a specialized pre-maturation medium that synchronizes their development, then transferred to a maturation medium containing hormones. By the next afternoon, roughly 24 hours later, the mature eggs are ready for fertilization.
- Fertilization and transfer: Mature eggs are fertilized using intracytoplasmic sperm injection (ICSI), where a single sperm is injected directly into each egg. Embryos develop for several days before transfer or freezing.
The entire active treatment window, from first stimulation shot to retrieval, can be as short as five days. Compare that to the two or more weeks of injections and monitoring in conventional IVF, and the appeal for many patients becomes clear.
Who Benefits Most From IVM
IVM was developed with a specific group of patients in mind: women with a high number of small follicles on their ovaries. That describes most women with PCOS, the most common hormonal disorder affecting women of reproductive age. PCOS patients tend to have many antral follicles, which makes them excellent candidates for IVM (more follicles means more eggs to collect) but also puts them at high risk for ovarian hyperstimulation syndrome (OHSS) during conventional IVF. OHSS is a potentially dangerous overreaction to fertility hormones that can cause severe bloating, fluid buildup, blood clots, and in rare cases hospitalization.
Because IVM uses little to no hormonal stimulation, it essentially eliminates the risk of OHSS. In a prospective multicenter study of IVM patients at risk for OHSS, none developed the condition. That safety advantage alone makes IVM a compelling option for this population.
Beyond PCOS, IVM is also used for:
- Cancer patients needing fertility preservation: Women diagnosed with leukemia or estrogen-sensitive breast cancer often can’t afford the time or the hormone exposure that standard IVF requires. IVM lets them freeze eggs or embryos quickly and without raising estrogen to the high levels seen in stimulated cycles.
- Women with hormone-sensitive conditions: Patients with blood clotting disorders or endometriosis may also benefit from avoiding the supraphysiologic estrogen levels produced during conventional stimulation.
- Women whose ovaries don’t respond to stimulation: When standard hormone protocols fail to produce mature follicles, IVM offers an alternative path by working with whatever follicles are naturally present.
Success Rates Compared to IVF
IVM success rates have improved significantly in recent years, though they still trail conventional IVF. The live birth rate after a first embryo transfer from an IVM cycle is roughly 31 to 35%, based on the largest studies to date using a newer two-step maturation technique called CAPA-IVM. When researchers tracked cumulative results over multiple transfers from a single egg retrieval cycle, the live birth rate climbed to about 44% at 12 months and 38.5% at 24 months.
For context, conventional IVF live birth rates per transfer typically range from about 30 to 50% depending on age and clinic, so the gap has narrowed considerably. That said, a randomized controlled trial comparing the two approaches could not demonstrate that IVM was equivalent to IVF in terms of live births. The tradeoff is real: slightly lower per-cycle success in exchange for fewer side effects, less medication, and lower cost.
Cost Differences
One of IVM’s clearest advantages is financial. A cost-effectiveness analysis found that the average cost per couple was roughly €4,300 for an IVM cycle compared to €6,493 for IVF. That’s about a 34% savings, driven almost entirely by the reduced need for expensive hormone medications and fewer monitoring visits. For patients who may need multiple cycles, those savings compound.
The same analysis noted that each additional live birth achieved by choosing IVF over IVM cost about €20,000. For women with a high antral follicle count, IVM was the less expensive option while producing only slightly lower cumulative birth rates. Whether the cost difference matters depends on your insurance coverage and how many cycles you’re willing to pursue, but for patients paying out of pocket, IVM can make fertility treatment more accessible.
Limitations to Be Aware Of
IVM isn’t suitable for everyone. Women with a low number of antral follicles, which includes many patients over 38 or those with diminished ovarian reserve, typically won’t produce enough immature eggs for the process to work well. The technique relies on having a good supply of small follicles to begin with.
The lab component is also more demanding than standard IVF. Maturing eggs outside the body requires precise culture conditions, and not every fertility clinic offers IVM. Maturation rates in the lab hover around 55 to 60% in many studies, meaning a significant portion of retrieved eggs won’t reach maturity. That’s why the procedure works best when there are many eggs to start with. If you’re considering IVM, look for a clinic with specific experience in the technique, as outcomes vary more between clinics than they do with conventional IVF.